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SHORT REPORT
Prenatal diagnosis of rare genetic conditions at a tertiary care hospital in Karachi
Kouser Karim, Dhanwanti Dileep, Shama Munim

Abstract
This study aims to observe the spectrum of Prenatal
Diagnosis of Rare Genetic conditions at a Tertiary care
hospital in Karachi. This is a retrospective review
conducted at the Aga Khan University Hospital, Karachi
from January 2016 to July 2018. All cases undergoing
invasive testing by Chorionic villus sampling for
indications other than Thalassemia were included. Forty
percent of patients in our cohort underwent invasive
testing for muscular dystrophies particularly survival
motor neuron (SMN) gene deletion and 32% for Cystic
Fibrosis. Other rare disorders like JAM 3 mutation, PEX 1
gene, Barters Syndrome, Wardenberg, Bardet-Beidl
Syndrome and Lissencephaly accounted for 28%.
Sophistication in laboratory technology and DNA
banking has improved the prenatal diagnosis of rare
genetic disorders particularly SMN gene deletion.
Integrated care involving foetal medicine specialist,
Paediatric geneticist, and dedicated Laboratory
personnel improves Counseling and Diagnosis of rare
genetic conditions. Provision of dedicated nursing staff
along with strengthening of welfare facility for nonaffording patients would improve the uptake of invasive
testing.
Keywords: CVS (chorionic villous sampling, SMN (Survival
motor neuron), SMA (spinal muscular atrophy).
https://doi.org/10.5455/JPMA.11601

Introduction
Chromosomal abnormalities and genetic disorders are
among the important causes of perinatal morbidity and
mortality.1 The prevalence of genetic disorders has been
increasing worldwide.1 It is even more common in the
under developed countries like Pakistan primarily due to
consanguinity and high birth rate.2 Consanguinity
accounts for 61.3 per cent of cases being more common
in rural than urban setting.3
Thalassemia is the leading single gene defect followed by
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Cystic fibrosis.4 Globally, there are 80 million carriers of βthalassemia. Around 5000-9000 children are born each
year with β-thalassemia in Pakistan (9.8 million carriers in
the total population).5 The frequency of delta F508 del in
cystic fibrosis patients is 60% in Pakistan.6
Other genetic disorders include survival motor neuron
(SMN) gene deletion and Duchene and Spinal muscular
dystrophies. SMN is an autosomal recessive
neurodegenerative disorder in which there is progressive
degeneration of alpha motor neurons leading to muscle
atrophy and paralysis.7-9 The exact prevalence of SMN
gene in our population is still not known but is seen in
relatively high numbers in the Genetics and Foetal
Medicine clinics.
Prenatal diagnosis of Genetic disorders is made by
invasive testing with Chorionic villous sampling
(CVS). 10 The procedure is commonly used for the
diagnosis of Thalassemia and Cystic Fibrosis. More
recently this procedure is being used for rare genetic
disorders in particular SMN deletion. In addition the
Laboratory is providing the service of DNA banking.
CVS is a preferred method as the amount of DNA
extracted is more as compared to Amniocentesis.11,12 It
has a miscarriage rate comparable to amniocentesis in
expert hands.13,14
This study describes the spectrum of rare genetic
disorders and their diagnosis at our Foetal Medicine unit
in collaboration with Paediatric Geneticist and
Laboratory. The findings will be helpful in future
counseling of patients and streamline referrals.

Methods
This is a retrospective review conducted at the Aga Khan
University Hospital, Karachi, Pakistan from 1st January
2016 to 31st July 2018. We included all cases undergoing
invasive testing by CVS for genetic conditions other than
Thalassemia. A prior Ethical Review Committee approval
was obtained.
The Aga Khan University is a private sector tertiary
referral hospital in Karachi and carries out more than
5800 deliveries annually. A third of these are high-risk
pregnancies. The University has four secondary care
hospitals with 15000 deliveries annually. The
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Obstetric department is backed up with a wellequipped state of the art 24 bedded Neonatal
Intensive Care Unit (NICU).

Table-1: Indications for Chorionic Villus Sampling.

Foetal medicine unit at the Aga Khan University caters for
all high risk pregnancies. The unit is one of the first
centers in Pakistan. More than 4000 ultrasound scans are
performed annually. Apart from inter and intradepartmental referrals the unit receives patients from all
over the country and some of the neighbouring countries
like UAE and Afghanistan. The services provided include
first trimester screening, genetic sonography, invasive
testing and genetic counseling.

Cystic Fibrosis
Muscular dystrophies
SMN Gene
Muscular dystrophy
Other genetic disorders
u JAM 3 mutation
u PEX 1 gene
u PW 569 gene (Nemaline Myopathy)
u Lissencephaly
u Barters Syndrome
u Wardenberg syndrome
u Bardet-Beidl Syndrome
Total procedures for genetic disorders other than thalessemia

In the recent years the Chorionic Villus sampling has been
made available for the diagnosis of genetic conditions
other than Thalassemia. This is mainly due to the
availability of DNA banking at our hospital. The procedure
of CVS is preferably performed from 12 weeks of gestation
onwards
Data was collected on pre-structured questionnaire from
hospital medical records. Data were entered and analyzed
by SPSS v. 20.0. Descriptive analysis was done and
frequencies were calculated for different indications of
CVS and their outcomes.

Results

Indication of CVS

Total procedures done
8 (32%)
10(40%)
8(32%)
2 (8%)
7 (28%)
1
1
1
1
1
1
1
25

In the last two years, there were 25 procedures for other
genetic disorders. Details are given in Table-1.
Ten (40%) cases were performed for muscular dystrophies
particularly spinal muscular atrophy (SMN gene deletion
32%). Details of results of other genetic disorders is given
in Table-2.
Outcomes of the cases are described in Table-3. There
were total 17 (68%) cases for whom outcome could

Table-2: CVS results for different indications other than thalassemia.
Indication for CVS
Cystic Fibrosis
SMN gene
Muscular dystrophy
Other genetic disorders
u JAM 3 mutation
u PEX 1 gene
u PW 569 gene (Nemaline Myopathy)
u Barters Syndrome
u Wardenberg syndrome
u Bardet-biedel syndrome
u Lissencephaly

Heterozygous

Homozygous

Normal

Inconclusive

6 (75%)
4 (50%)
-

1(12.5%)

2(25%)
2 (25%)
2 (100%)

1(12.5%)

1
1

1
1
1
1
1

Table-3: Outcome of CVS cases.

Cystic Fibrosis
SMN gene
Muscular dystrophy
Other genetic disorders
Total

Livebirth
n (%)

Miscarriage
n (%)

TOP
n (%)

IUD
n (%)

NND
n (%)

Lost to follow up
n (%)

Ongoing pregnancies
n (%)

2 (25%)
1(12.5%)
4(62.5%)
7(28%)

1 (100%)
1(4%)

1 (100%)

-

0

5 (62.5%)
1 (12.5%)
1 (12.5%)
1 (12.5%)
8(32%)

3 (37.5%)
3 (37.5%)
2(25%)
8(32%)

1(4%)

0

TOP: Termination of Pregnancy. IUD: Intrauterine Death. NND: Neonatal Death, SMN: Survival Motor Neuron.
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not be determined among which 9 (36%) are with
ongoing pregnancies and 8 (32%) cases were lost to
follow up as they were only referred to the tertiary
care for prenatal diagnosis.

Discussion
Genetic disorders are emerging as the important causes
of perinatal morbidity and morbidity.1 Worldwide the
prevalence of single gene disorders is 10/1000 births
(WHO 2013). The most common being thalassemia
followed by cystic fibrosis.4
SMN gene deletion is among the less commonly
diagnosed disorder. The global prevalence of which is
around 1-2 per 100,000.8 The carrier frequency of SMN is 1
in 35 to 1 in 50 in the general population.15,16 A higher
prevalence of SMA has been reported in Iran, Saudi
Arabia, Egypt and Pakistan. This could largely be
attributed to the higher rate of Consanguinity.8.17 In a
another series consanguinity in Pakistan was as high as
68% in babies with SMN gene deletions.8 Though the
exact prevalence of this condition in Pakistan remains
unknown, in our study 32% of the CVS were done for SMN
deletions.
Invasive testing for aneuploidy has been available since
the inception of the Foetal Medicine services at the
University. In the last couple of years the spectrum of
prenatal diagnostic facility has expanded with the
introduction of SMN and DMD gene testing locally.
Foetomaternal section is a dedicated department to
provide monitoring and prenatal diagnosis in our unit.
This unit offers first trimester screening, Genetic
Sonogram and monitoring of all high risk women with
Doppler scan, ultrasound and Preterm delivery screening.
Counseling remains a vital part of management of high
risk pregnancy. In addition to foetal medicine specialist,
we have Paediatric geneticist and counseling services. As
prenatal diagnosis is now becoming better, clinicians
have to counsel the parents with certain disorders.
Counseling remains a challenge in the absence of the
region-specific data.
Improvement in laboratory techniques along with the
foetal medicine services have largely contributed to
improved outcome of pregnancies with poor pregnancy
outcome. In the last 18 months, DNA banking has also
been started in Aga Khan University. It allows
conservation of genetic material and significant amount
of DNA for multiple testing of an individual in future.18-20
Our study clearly indicates that collaboration with
reference laboratories and improvement in DNA
extraction can broaden the scope of work. As this
improves, the number of patients with undetermined
Vol. 70, No. 4, April 2020

cause of poor pregnancy outcome would decline.
Provision of new diagnostic tests obviously warrants an
improvement in the provision of welfare to deserving and
non-affording patients. Our unit is working closely with
the welfare department to facilitate and help the needy
patients. A large number of patients accessing our facility
belong to middle /low income strata.
One of the limitations of our study is that the lost to
follow up was around 32%. This can be explained by the
fact that vast majority of referrals for Prenatal Diagnosis
are from outside Karachi. In addition, there is no
dedicated nursing staff to collect the follow up. Trained
nurses can play a role in counseling and data keeping in
such cases.

Conclusion
Prenatal diagnosis for genetic disorders other than
Thalassemia has been made available. This is primarily
due the facility of DNA banking. This has led to testing
other disorders particularly SMN gene deletion locally.
Multidisciplinary input with Genetic Counseling,
dedicated specialty personnel and external linkages have
improved the scope of this work. Provision of welfare
would benefit greater number of patients.
Disclaimer: None to declare.
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